background
acut
viral
respiratori
infect
repres
global
import
caus
morbid
mortal
childhood
individu
cellular
respons
appear
play
critic
role
recoveri
infect
given
individu
impair
cellular
immun
congenit
acquir
sever
diseas
secret
viru
longer
period
object
aim
studi
immunohistochem
evalu
express
cell
surfac
antigen
pneumon
infiltr
alveolar
septa
use
paraffinembed
lung
sampl
autopsi
immunocompet
children
die
lethal
nonpandem
sever
acut
respiratori
infect
studi
design
case
pediatr
autopsi
patient
sever
respiratori
diseas
case
select
studi
identifi
subpopul
inflammatori
cell
alveolar
septa
cell
surfac
antigen
express
assess
immunohistochemistri
use
follow
primari
antibodi
result
lymphocyt
count
higher
virusposit
group
p
also
much
higher
among
case
posit
three
viral
type
p
fewer
cell
case
adv
adenoviru
infect
p
predomin
cell
histopatholog
pattern
defin
interstiti
pneumon
p
conclus
result
studi
demonstr
lymphocyt
present
alveolar
septa
particip
greater
extent
respons
toward
viral
pneumonia
cell
number
often
reduc
case
adv
acut
respiratori
infect
major
worldwid
caus
morbid
mortal
childhood
particularli
develop
countri
data
world
health
organ
shown
last
decad
approxim
onethird
global
mortal
children
account
million
annual
death
caus
acut
respiratori
infect
common
virus
caus
viral
pneumonia
influenza
viru
flu
flu
b
parainfluenza
adenoviru
adv
respiratori
syncyti
viru
rsv
respiratori
tract
humor
immun
influenza
virus
involv
neutral
antibodi
immunoglobulin
lymphocyt
b
plasma
cell
respect
cellular
immun
respons
lymphocyt
attract
immun
cell
respons
major
histocompat
mhc
class
ii
antigen
present
cytotox
lymphocyt
induc
mhc
class
type
respons
respons
lead
product
interferongamma
tumor
necrosi
factor
tnf
induc
lysi
infect
cell
http
elsevi
bv
right
reserv
caus
apoptosi
natur
infect
normal
children
respond
prolifer
specif
cytotox
lymphocyt
suggest
stimul
cell
lymphocyt
involv
rsv
replic
infect
rat
cytotox
lymphocyt
respons
elimin
viru
lung
howev
paradox
appear
increas
symptom
sever
observ
helper
lymphocyt
protect
role
may
simultan
increas
diseas
sever
predomin
stimul
lymphocyt
may
associ
occurr
diseas
increas
sever
aim
studi
evalu
pneumon
infiltr
assess
immunohistochem
express
cell
surfac
antigen
case
pediatr
autopsi
patient
sever
respiratori
infecti
diseas
formalin
fix
paraffin
embebd
lung
sampl
n
select
studi
stillbirth
neonat
death
children
immunodefici
also
exclud
total
sampl
n
age
individu
includ
studi
rang
one
month
year
age
case
divid
two
group
year
year
date
death
use
defin
season
divid
warm
cold
month
anatomopatholog
pattern
sampl
studi
review
section
stain
hematoxylineosin
classifi
either
bronchopneumonia
interstiti
pneumon
identifi
subset
inflammatori
cell
immunohistochemistri
use
follow
primari
antibodi
identif
thelper
cell
cytotox
cell
antibodi
monocyt
macrophag
histiocyt
interleukin
receptor
lymphocyt
immun
respons
regul
cell
express
mhc
class
ii
includ
b
lymphocyt
macrophag
antihuman
mous
monoclon
novocastra
tm
new
castl
upon
tyne
unit
kingdom
tissu
microarray
tma
contain
four
sampl
per
case
two
peribronchi
area
two
subpleur
peripher
area
construct
tma
slide
stain
togeth
neg
control
slide
primari
antibodi
ad
posit
control
slide
human
tonsil
sampl
immunohistochemistri
immunoperoxidas
assay
report
chong
colleagu
use
modif
antigen
retriev
perform
use
biosb
imunoretriev
santa
ca
usa
sampl
incub
secondari
antibodi
dako
advanc
tm
hrp
system
dakocytom
inc
ca
usa
min
case
alreadi
test
use
immunohistochemistri
protocol
describ
respiratori
virus
use
antibodi
antirsv
antiadv
antiflua
flub
use
light
diagnost
tm
respiratori
viral
screen
dfa
kit
chemicon
intern
inc
temecula
ca
usa
tma
plate
analyz
olympu
microscop
olympu
optic
co
ltda
japan
magnif
without
prior
inform
viral
posit
sampl
case
highpow
field
hpf
randomli
select
field
number
posit
cell
quantifi
total
cell
per
case
hpf
use
statist
calcul
nonparametr
kruskalw
test
use
compar
two
group
regard
quantit
variabl
fisher
exact
test
chisquar
test
use
compar
two
group
regard
categor
variabl
p
valu
consid
statist
signific
common
viral
type
identifi
studi
rsv
n
furthermor
case
concomit
viral
infect
posit
three
virus
tabl
regard
children
sex
age
season
histopatholog
pattern
statist
predomin
group
relat
presenc
absenc
viru
see
tabl
predomin
case
neg
viru
n
compar
posit
case
n
shown
tabl
statist
signific
differ
virusposit
virusneg
group
term
posit
howev
found
lymphocyt
present
significantli
higher
number
virusposit
group
p
similarli
result
obtain
cell
p
present
higher
number
virusneg
group
see
tabl
result
tabl
show
comparison
case
pure
rsv
n
pure
adv
n
virusneg
group
fewer
cell
advposit
case
virusneg
group
p
count
posit
cell
also
analyz
case
posit
pure
n
pure
n
pure
flua
n
pure
flu
b
n
case
compar
virusneg
group
statist
signific
differ
cell
count
also
analyz
count
posit
cell
case
posit
combin
adv
rsv
flu
b
adv
case
occur
associ
anoth
viru
n
cell
n
virusneg
group
n
p
fewer
cell
n
viru
neg
group
n
p
signific
correl
patient
cell
popul
sex
age
season
howev
analyz
term
histopatholog
pattern
lung
injuri
observ
patient
interstiti
pneumon
n
greater
number
cell
patient
bronchopneumonia
n
p
furthermor
patient
virus
n
greater
number
lymphocyt
patient
virus
n
p
sex
distribut
popul
studi
show
slight
predomin
male
femal
studi
develop
develop
countri
male
femal
affect
respiratori
infect
studi
sampl
n
children
year
age
previous
report
literatur
predomin
death
colder
month
compar
warmer
month
respiratori
virus
rsv
show
characterist
season
alreadi
well
document
studi
develop
develop
countri
bronchopneumonia
common
histopatholog
pattern
repres
total
sampl
classic
bronchopneumonia
lobar
pneumonia
histopatholog
pattern
describ
lung
infect
caus
bacteria
howev
numer
studi
shown
respiratori
virus
alon
concomit
viralbacteri
infect
also
etiolog
agent
find
thu
patient
morpholog
pattern
characterist
bacteri
etiolog
lung
infect
exist
viral
concomit
also
like
case
believ
respiratori
virus
favor
entri
spread
bacteria
local
system
studi
case
posit
viral
antigen
result
preval
case
posit
viru
immunohistochemistri
studi
method
indirect
immunofluoresc
corrobor
result
report
viral
posit
acut
respiratori
childhood
infect
rang
analysi
viral
type
rsv
commonli
identifi
viru
rsv
also
common
agent
identifi
studi
report
caus
sever
pneumonia
unit
state
itali
south
korea
uruguay
brazil
situ
hybrid
immunohistochemistri
analysi
respiratori
infect
demonstr
presenc
viru
bronchial
epitheli
cell
singl
alveolar
epitheli
cell
especi
recent
infect
day
hospit
lack
antigen
detect
virus
alveolar
epitheli
cell
may
relat
long
time
cours
infect
studi
observ
bronchial
bronchiol
alveolar
epitheli
cell
posit
viral
antigen
immunohistochemistri
sampl
patient
die
averag
day
post
hospit
besid
limit
amount
tissu
analyz
tma
techniqu
offer
mani
benefit
uniform
stain
reaction
also
help
prevent
necrot
hemorrhag
area
may
complic
immunohistochemistri
assess
import
mention
look
seven
virus
studi
import
pediatr
respiratori
virus
rhinoviru
metapneumoviru
coronavirus
analyz
clearli
inclus
latter
virus
studi
may
increas
number
posit
sampl
immunophenotyp
sampl
reveal
predomin
cell
median
signific
differ
virusposit
virusneg
case
moreov
cell
count
also
high
median
sampl
contrast
cell
count
number
studi
sampl
median
addit
number
cell
significantli
differ
virusposit
virusneg
group
howev
cell
lymphocyt
macrophag
detect
case
median
statist
signific
differ
observ
compar
virusposit
virusneg
group
differ
number
cell
type
due
differ
present
pneumonia
patholog
reaction
host
along
differ
etiolog
agent
length
hospit
durat
ill
one
reason
observ
high
number
cell
express
fact
case
studi
involv
patient
bronchopneumonia
like
pure
bacteri
concomitantli
viral
sampl
cell
express
mhc
class
ii
marker
mainli
b
lymphocyt
histiocyt
macrophag
cell
express
gener
monocyt
marker
mainli
histiocyt
macrophag
bronchopneumonia
usual
bacteri
lesion
pattern
mainli
character
neutrophil
exud
neutrophil
attract
focu
infect
chemotact
cytokin
releas
immun
cell
mainli
macrophag
b
lymphocyt
gener
differenti
subsequ
mhc
class
ii
bacteri
antigen
present
moreov
immunohistochemistri
case
show
viral
marker
bronchopneumonia
pattern
predomin
observ
lead
us
believ
case
treat
pure
bacteri
pneumonia
character
high
concentr
neutrophil
acut
phase
inflammatori
respons
mainli
mediat
mhc
class
ii
resolut
phase
mediat
histiocyt
anoth
interest
point
case
patient
alreadi
die
hospit
time
rel
high
averag
day
regardless
histopatholog
pattern
found
accordingli
patient
standard
pulmonari
patholog
alreadi
resolut
phase
larg
amount
histiocyt
common
observ
would
explain
overal
preval
marker
studi
even
though
differ
group
without
viru
statist
signific
cell
gener
rare
inflammatori
process
function
regul
lymphocyt
immun
respons
would
explain
low
number
observ
sampl
addit
signific
differ
virusposit
virusneg
group
modul
respons
median
number
cell
low
case
cell
hpf
present
statist
signific
differ
cell
usual
thelper
lymphocyt
immun
respons
therefor
present
case
pneumon
skew
toward
lymphocyt
respons
case
bronchopneumonia
skew
toward
neutrophil
respons
observ
hpf
mean
number
lymphocyt
total
sampl
statist
signific
differ
count
compar
virusposit
case
lymphocyt
hpf
virusneg
case
lymphocyt
hpf
virusposit
case
present
higher
number
lymphocyt
case
posit
virus
p
p
respect
respiratori
virus
capabl
induc
hyperrespons
airway
activ
respons
respons
usual
predomin
accordingli
stain
antibodi
reveal
greater
number
lymphocyt
virusposit
case
indic
preval
activ
prolifer
cytotox
lymphocyt
suggest
immun
respons
controversi
literatur
regard
immun
respons
mediat
lymphocyt
studi
shown
respons
fundament
import
rsv
pathogenesi
subsequ
thorburn
show
rsv
inhibit
express
lymphocyt
pulmonari
parenchyma
develop
memori
cell
rsv
seem
interfer
receptor
signal
cell
corrobor
data
studi
also
found
larg
number
lymphocyt
macrophag
lung
sampl
indic
involv
respons
immun
respons
mechan
may
due
predomin
posit
rsv
case
studi
could
interf
final
count
inflammatori
cell
virusposit
group
thu
differ
assess
analyz
case
pure
rsv
shown
tabl
specif
compar
pure
rsv
case
neg
case
fewer
cell
mild
increas
number
case
pure
adv
compar
neg
case
reduct
lymphocyt
count
increas
p
cell
neg
group
data
suggest
case
adv
may
contribut
increas
number
lymphocyt
case
viral
posit
fact
could
also
suggest
pulmonari
inflammatori
process
caus
adv
involv
activ
respons
inhibit
respons
previous
suggest
author
result
studi
demonstr
case
viral
pneumonia
greater
number
lymphocyt
present
alveolar
septa
addit
case
adv
fewer
number
cell
none
declar
none
declar
ethic
review
board
hcufpr
review
approv
studi
regist
number
august
